THE EFFECT OF METHYLPREDNISOLONE ON LYMPHOCYTE PHENOTYPE AND FUNCTION IN PATIENTS WITH MULTIPLE-SCLEROSIS

被引:18
作者
KIRK, P
COMPSTON, A
机构
[1] Section of Neurology, Department of Medicine, University of Wales College of Medicine, Cardiff, CF4 4XN, Heath Park
关键词
Lymphocyte function; Lymphocyte phenotype; Methylprednisolone; Multiple sclerosis;
D O I
10.1016/0165-5728(90)90114-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The extent to which symptomatic improvement in patients with multiple sclerosis treated with intravenous methylprednisolone depends on immunological actions of corticosteroids is unknown. In this study the effect of methylprednisolone on circulating T and B cell function has been assessed in vitro and in vivo. Low molar concentrations of methylprednisolone increased pokeweed mitogen-stimulated IgG synthesis by unfractionated lymphocytes in 20 patients with multiple sclerosis and 15 controls. Treatment with methylprednisolone was associated with increased IgG synthesis in a further cohort of 26 affected individuals although dose responsiveness to methylprednisolone was uninfluenced in these patients. Sequential concanavalin A-pokeweed mitogen-induced IgG synthesis by mononuclear cells was also stimulated by methylprednisolone. Phenotypic analysis of paired samples from 12 patients with multiple sclerosis, taken before and after treatment showed no alteration in CD4 or CD8 cells, their suppressor inducer or suppressor subpopulations or activated lymphocytes. © 1990.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 24 条
[1]  
BELLAMY AS, 1985, CLIN EXP IMMUNOL, V61, P248
[2]   A DOUBLE-BLIND CONTROLLED TRIAL OF HIGH-DOSE METHYLPREDNISOLONE IN PATIENTS WITH MULTIPLE-SCLEROSIS .2. LABORATORY RESULTS [J].
COMPSTON, DAS ;
MILLIGAN, NM ;
HUGHES, PJ ;
GIBBS, J ;
MCBROOM, V ;
MORGAN, BP ;
CAMPBELL, AK .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (05) :517-522
[3]   HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE IN THE TREATMENT OF MULTIPLE-SCLEROSIS - CLINICAL-IMMUNOLOGICAL CORRELATIONS [J].
DURELLI, L ;
COCITO, D ;
RICCIO, A ;
BARILE, C ;
BERGAMASCO, B ;
BAGGIO, GF ;
PERLA, F ;
DELSEDIME, M ;
GUSMAROLI, G ;
BERGAMINI, L .
NEUROLOGY, 1986, 36 (02) :238-243
[4]  
FAUCI AS, 1977, J IMMUNOL, V119, P598
[5]   ACTIVATED LYMPHOCYTES-T IN PATIENTS WITH MULTIPLE-SCLEROSIS [J].
GOLAZ, J ;
STECK, A ;
MORETTA, L .
NEUROLOGY, 1983, 33 (10) :1371-1373
[6]   ABNORMAL REGULATION OF IGG PRODUCTION IN MULTIPLE-SCLEROSIS [J].
GOUST, JM ;
HOGAN, EL ;
ARNAUD, P .
NEUROLOGY, 1982, 32 (03) :228-234
[7]   DEFECTIVE IMMUNOREGULATION IN MULTIPLE-SCLEROSIS [J].
GOUST, JM ;
HOFFMAN, PM ;
PRYJMA, J ;
HOGAN, EL ;
FUDENBERG, HH .
ANNALS OF NEUROLOGY, 1980, 8 (05) :526-533
[8]   INVIVO ACTIVATED LYMPHOCYTES-T IN THE PERIPHERAL-BLOOD AND CEREBROSPINAL-FLUID OF PATIENTS WITH MULTIPLE-SCLEROSIS [J].
HAFLER, DA ;
FOX, DA ;
MANNING, ME ;
SCHLOSSMAN, SF ;
REINHERZ, EL ;
WEINER, HL .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (22) :1405-1411
[9]   MECHANISMS OF CORTICOSTEROID ACTION ON LYMPHOCYTE SUB-POPULATIONS .4. EFFECTS OF INVITRO HYDROCORTISONE ON NATURALLY OCCURRING AND MITOGEN-INDUCED SUPPRESSOR CELLS IN MAN [J].
HAYNES, BF ;
FAUCI, AS .
CELLULAR IMMUNOLOGY, 1979, 44 (01) :157-168
[10]  
HEILMAN DH, 1973, CLIN EXP IMMUNOL, V15, P203